Wednesday, 22 April 2020
Interim Report January – March 2020
The interim report for January - March 2020 is now available.
You'll find it below in PDF-format.
For more information, contact
Berit Lindholm, CEO Bluefish Pharmaceuticals
Tel. 46 8 519 116 00
About Bluefish Pharmaceuticals
Bluefish has undergone significant international expansion since the company was founded in 2005. Bluefish focuses on the development, manufacture and sale of generic pharmaceuticals. The company conducts marketing operations in a large number of European markets and is expanding into territories outside Europe. The product portfolio consists of a total of approximately 80 products and is growing.
Interim report January-March 2020